Franck Assayag
Le Chesnay, 78150, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Preliminary evaluation of the interest of a therapeutic optimization cell on the titration of treatments for heart failure with reduced left ventricular ejection fraction and the quality of life of patients
Journal: Annales de cardiologie et d'angeiologie
Published: July 28, 2024
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Journal: Current oncology (Toronto, Ont.)
Published: August 14, 2023
Two-photon microscopy for microrobotics: Visualization of micro-agents below fixed tissue.
Journal: PloS one
Published: February 23, 2023
Home treatment of low-risk pulmonary embolism patients : Efficacy and safety of an outpatient program including the general practitioner
Journal: Annales de cardiologie et d'angeiologie
Published: June 17, 2022
In vitro bone metastasis dwelling in a 3D bioengineered niche.
Journal: Biomaterials
Published: August 04, 2020
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.
Journal: Blood cells, molecules & diseases
Published: November 14, 2018
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Journal: International journal of cancer
Published: September 19, 2018
The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers.
Journal: The Journal of pathology
Published: February 22, 2018
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2017
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.
Journal: Oncotarget
Published: September 26, 2017
Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition.
Journal: Oncotarget
Published: April 27, 2017
Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts.
Journal: Investigative ophthalmology & visual science
Published: September 23, 2016
Last Updated: 09/26/2026